(Press-News.org) Smoke inhalation is the major cause of death in fire victims due to cyanide poisoning. However, new research presented at CHEST 2012, the annual meeting of the American College of Chest Physicians, shows that a new antidote, cobinamide, may help reverse the effects of cyanide toxicity. Researchers from multiple institutions, including the University of California Irvine Medical Center, exposed six ventilator-supported New Zealand white rabbits to cold smoke breaths until toxic carbon monoxide levels were achieved, concurrent with intravenous cyanide infusion. Intravenous cobinamide was administered in treatment arm animals and compared with control responses. Results showed that intravenous cobinamide reversed cyanide toxicity in these animals in the face of smoke-induced carbon monoxide exposure, without evident adverse effects. Researchers concluded that cobinamide shows promise as a potential antidote for cyanide poisoning in smoke inhalation victims and that it could potentially be administered in mass casualty exposure scenarios. This study was presented during CHEST 2012, the annual meeting of the American College of Chest Physicians, held October 20 – 25, in Atlanta, Georgia.
### END
New antidote for smoke-related cyanide toxicity shows promise
2012-10-22
ELSE PRESS RELEASES FROM THIS DATE:
Mold exposure at home could increase risk for sarcoidosis
2012-10-22
People who are exposed to mold in their homes could be at an increased risk for sarcoidosis, a chronic inflammatory lung disease. Researchers from Sweden and Slovenia tested 62 nonsmoking patients with sarcoidosis, 34 of whom had extrapulmonary manifestations (EPM). Patients were tested for β-glucan, an immune-modulating agent found in fungi, and accompanying inflammatory biomarkers, including interleukin (IL)-6, IL-10, and IL-12. Serum samples were also obtained from 18 control subjects with no pulmonary disease or respiratory symptoms. Results showed that levels ...
Statins may help prolong survival in NSCLC resection
2012-10-22
Patients who have undergone resection for non-small cell lung cancer (NSCLC) may improve their overall survival and reduce the risk of recurrence by taking statins. Researchers from Northwestern University Feinberg School of Medicine, Chicago, and Penn State Hershey Cancer Institute followed 803 patients who underwent resection for NSCLC, of which 315 were using statins. Results showed that statin use was associated with a significantly lower local recurrence rate and significantly higher overall survival compared with non-statin users. Researchers conclude that prospective ...
Excessive daytime sleepiness common in high school students
2012-10-22
New research shows that high school students experience excessive daytime sleepiness (EDS), with most students sleeping fewer than 7 hours per night. Researchers from West Virginia University surveyed 141 high school students, of which 28.4% were either obese or overweight. Overall, 39% of the students surveyed experienced EDS with an Epworth Sleepiness Scale (ESS) of >10, and were more likely to report perception of inadequate or nonrefreshing sleep than those with ESS < 10. However, the duration of sleep was less than 7 hours per night in both groups. There was no difference ...
More GI bleeding seen in atrial fibrillation patients on rivaroxaban than warfarin
2012-10-22
Patients with atrial fibrillation (AF) experienced more major and non-major clinically relevant GI bleeding when taking rivaroxaban than patients taking warfarin. As part of the ROCKET AF trial, researchers from multiple institutions, including Harvard Medical School; Mount Sinai Medical Center; Janssen Research & Development; and Bayer HealthCare Pharmaceuticals, randomized 14,264 patients with nonvalvular AF to receive either rivaroxaban or dose-adjusted warfarin. Post-hoc analysis was performed on all patients while receiving study medication until 2 days after the last ...
Difficulty breathing, chest pain, and cough key symptoms for embolism
2012-10-22
Difficulty breathing, chest pain, and cough may sound like symptoms of a heart attack; however, new research shows that these are the key symptoms for pulmonary embolism (PE), a potentially fatal blockage in the lung. A research team from Saint Vincent's Medical Center in Bridgeport, Connecticut, retrospectively reviewed the clinical features, risk factors, and ECG findings in 334 patients with confirmed PE. Results showed that dyspnea or difficulty breathing, chest pain, and cough were present in 72%, 38%, and 19% of the patients, respectively, and dyspnea was the only ...
Pulmonary hypertension deaths and hospitalizations on the rise
2012-10-22
New research indicates an increase in the number of US deaths and hospitalizations related to pulmonary hypertension. A research team from Howard University Hospital, Washington, DC, examined multiple cause of death mortality data from the National Vital Statistics System and hospital discharge data from the National Hospital Discharge Survey for 1999-2009. Results showed that since 1999, the number of deaths and hospitalizations, as well as death rates and hospitalization rates, have increased for pulmonary hypertension, particularly among women and older adults. During ...
Pulmonary hypertension combination therapy may lead to greater disease burden
2012-10-22
Patients with pulmonary arterial hypertension (PAH) receiving combination therapy with intravenous (IV) PGI2 may suffer from greater disease burden compared with those receiving monotherapy or combination therapy, excluding IV PGI2. Researchers from Massachusetts General Hospital and Novartis Pharma AG in Switzerland performed statistical tests on 446 patients with PAH, of which (a) 337 were receiving monotherapy; (b) 88 were receiving non-IV PGI2 combination therapy; and (c) 21 were receiving IV PGI2 combination therapy. Results showed that pulmonary vascular resistance, ...
Guideline implementation may impact VTE quality of care
2012-10-22
The quality of care of patients hospitalized with venous thromboembolism (VTE) significantly improved between 2005 and 2009, and researchers suggest these improvements may be due to the implementation of VTE treatment guidelines. Using data from the Nationwide Inpatient Sample, researchers from Inova Fairfax Hospital and Betty and Guy Beatty Center for Integrated Research, Falls Church, Virginia, reviewed quality care measures in 800,000 VTE discharges that took place from 2005 to 2009. Results showed that in-hospital mortality and length of stay decreased during this time, ...
Trainee presence during endobronchial ultrasound increases complications
2012-10-22
The presence of a trainee during endobronchial ultrasound (EBUS) may have negative implications, including increased procedure time and complications. Researchers from the University of Calgary retrospectively reviewed 607 EBUS procedures, of which a trainee was present for 512. Significant differences were seen when a trainee was present vs when no trainee was present for procedure length (58.32 vs 37.69 min) and for the dose of propofol used (178.28 vs 137.11 mg). In addition, more complications were seen in the trainee group (24 vs 1). This study was presented during ...
10-minute 'tension tamer' can help reduce stress and improve sleep
2012-10-22
A simple, 10-minute stress reduction technique could help to relieve stress, improve sleep quality, and decrease fatigue. Researchers from Walter Reed National Military Medical Center, Bethesda, Maryland, attempted to determine the effect of a brief, stress reduction technique, the 10-minute Tension Tamer, on improvement of stress levels and sleep parameters in 334 patients in a heart health program. After a 30-minute introductory workshop, subjects were given instruction and guided opportunities to practice 10-minute Tension Tamers over the course of four 30-minute visits ...